Drug Type Small molecule drug |
Synonyms (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol, all-trans-retinol, all-trans-retinyl alcohol + [12] |
Target |
Action agonists |
Mechanism RARs agonists(Retinoic acid receptors agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (10 Aug 1976), |
Regulation- |
Molecular FormulaC20H30O |
InChIKeyFPIPGXGPPPQFEQ-OVSJKPMPSA-N |
CAS Registry68-26-8 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Ichthyosis Vulgaris | Japan | 08 Sep 1979 | |
Pityriasis | Japan | 08 Sep 1979 | |
Keratomalacia | Japan | 10 Aug 1976 | |
Keratosis | Japan | 10 Aug 1976 | |
Night Blindness | Japan | 10 Aug 1976 | |
Vitamin a Deficiency | Japan | 10 Aug 1976 | |
Xerophthalmia | - | - | - |
Not Applicable | Hydatidiform Mole β-HCG | - | kxhyojgzxi(zxqbohnkmh) = tttjhkkqic vfrscqrocw (wyjfmtjjqx ) | Positive | 10 Mar 2024 | ||
Not Applicable | - | 50 | Oral vitamin A supplementation + topical retinoic acid gel | lrdixmvyaf(igmsxutxdl) = hotfqkuvar ebmhavfmnp (jykmnpnekk ) | Positive | 11 Oct 2023 | |
Topical retinoic acid gel alone | lrdixmvyaf(igmsxutxdl) = ictfauwygr ebmhavfmnp (jykmnpnekk ) | ||||||
Not Applicable | - | High-dose oral vitamin A | bclhpvqawu(wwvrrcapxj) = dzimryrnas lgakatycte (ctkhbjicyx ) View more | Positive | 01 Feb 2023 | ||
Placebo | bclhpvqawu(wwvrrcapxj) = duxthztdaw lgakatycte (ctkhbjicyx ) View more | ||||||
Not Applicable | - | Vitamin A Toxicity | lqarcleyxn(oetfpuvxmz) = vaciuahbjo lmhdncufnq (xqyaksyowi ) | - | 03 Nov 2022 | ||
Not Applicable | - | (AMD group) | srayyjdizr(glbsqglshp) = jantclsghp mutzpyslbu (vwexzraesy ) | - | 01 Sep 2022 | ||
(RPD group) | srayyjdizr(glbsqglshp) = ubwgezorys mutzpyslbu (vwexzraesy ) | ||||||
Phase 3 | 807 | Vitamin A therapy | hnkxkgnixn(pvjcswgkte): RR = 0.89 (95% CI, 0.8 - 0.99) | Positive | 15 May 2021 | ||
(Control group) | |||||||
Not Applicable | 188 | Enteral water-soluble vitamin A | usexqsfjzm(lquqiktzam) = cyvasswsuh sippjcekbi (ffwsihoygk ) View more | - | 01 Jan 2021 | ||
Placebo | usexqsfjzm(lquqiktzam) = fzrlktltnu sippjcekbi (ffwsihoygk ) View more | ||||||
Not Applicable | 112 | Vitamin A supplementation | jyqebyygyi(exojrszzjw) = mbbezvxdpz qeuzixytag (cewzqbxheu ) | - | 01 Dec 2018 | ||
(Placebo) | jyqebyygyi(exojrszzjw) = ewvsgfhcve qeuzixytag (cewzqbxheu ) | ||||||
Not Applicable | - | (Retina) | pftdirjobc(hsbvlagodm) = zdouknlyil ljnwdmbrus (reodcazuub ) | - | 17 Nov 2014 | ||
(Iris) | pftdirjobc(hsbvlagodm) = qknovzbsvz ljnwdmbrus (reodcazuub ) | ||||||
Phase 4 | - | 7,587 | Vitamin A supplementation | dmstqmatju(prrjqxpcvj): MRR = 0.91 (95% CI, 0.59 - 1.41) | - | 01 Sep 2014 | |
(Placebo) |